Speaker Name(s): Lally School of Management & Technology
Description: Arthur J. Coury, Ph.D. Vice President, Biomaterials Research Genzyme Corporation Tissue engineering involves the systematic control of cells, matrices and fluids of the body. A narrow interpretation of the field indicates limited commercial success. Broadly interpreted to include "tissue engineering products" as well as "engineered tissue products," significant success has been realized, with high promise for attracting practitioners, resources and a positive public image. The field is inevitably poised for vigorous future growth, albeit with significant challenges.